CN Patent

CN101087752A — 调节rar受体的新配体，及其在人类药品和化妆品中的用途

Assigned to Galderma Research and Development SNC · Expires 2007-12-12 · 18y expired

What this patent protects

本发明涉及符合以下通式(I)的新的化合物；含有它们的组合物；用于制备它们的方法以及它们在计划用于人或兽医的药物组合物中的用途，或者它们在化妆品组合物中的用途。

USPTO Abstract

本发明涉及符合以下通式(I)的新的化合物；含有它们的组合物；用于制备它们的方法以及它们在计划用于人或兽医的药物组合物中的用途，或者它们在化妆品组合物中的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN101087752A
Jurisdiction
CN
Classification
—
Expires
2007-12-12
Drug substance claim
No
Drug product claim
No
Assignee
Galderma Research and Development SNC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.